3620 results for «2412»
3620 results
The cathlab of the future
17 May 2022 – From EuroPCR 2022
Let's take the practical case of an 84-year-old male patient with hypertension, dyslipidaemia, and severe aortic stenosis: in this EuroPCR 2022 session, find out how to treat such a patient in the cathlab of the future and discuss the benefits of non-invasive technology at tableside, tools...
EuroPCR 2022 Hotlines / Late-Breaking Trials in hypertension management: SPYRAL-HTN ON MED, radiance HTN SOLO and TRIO, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in hypertension management! Blood pressure and MACE reductions after renal denervation: 3-year GSR results, patient-level pooled analysis of ultrasound RDN in radiance-HTN SOLO and Trio, and SPYRAL-HTN ON MED 3 year data.
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.
Advancing the treatment of uncontrolled hypertension with ultrasound renal denervation
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session, which covers the latest clinical evidence around catheter-based ultrasound renal denervation, will also enable you to appreciate the distinct features of this approach, to understand perspectives on patient selection and patient preference, and to learn how to introduce and establish interventional hypertension therapy.
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary artery disease: MASTER DAPT, CRUZ-HBR, DISCO RADIAL, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary artery disease! Abbreviated DAPT after complex PCI in high bleeding risk patients, comparing conventional and haemostatic dressings in radial access, angio-based QFR virtual PCI vs. conventional angio-guided PCI, CRUZ-HBR, CT-guided invasive coronary angiography in patients with...
Towards a personalised coronary intervention with CT-guided robotic-assisted PCI
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to show how coronary CT angiography can help in pre-procedural planning and guidance of PCI to achieve the best patient outcomes. It also explores the role of robotic-assisted PCI in improving procedural accuracy, radiation safety, and ergonomics within the cathlab. Finally, it demonstrates how...
Start treating refractory angina patients with Reducer therapy - Practical aspects
17 May 2022 – From EuroPCR 2022
Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...
EuroPCR 2022 Early experience and registry results in TAVI: Optimize PRO, FORWARD PRO, Neo-Align, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in TAVI! ACURATE neo2 post-procedural hemodynamic outcomes, first real-world results of the JenaValve TAVI system, Optimize PRO study, a next-generation aortic transcatheter heart valve, commissural alignment, and three-year outcomes following TAVI with a self-expanding valve with pericardial wrap.
DCB and the possibility of a clean vessel
17 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to show, based on real-life cases, that even complex coronary disease can be treated without the need for permanent coronary stents. Learn how to prepare the vessel, deliver the therapy, and assess immediate outcomes after "DCB-alone" PCI, discuss de novo, small vessels, and...
2022: a tipping point in the treatment of mitral regurgitation patients
17 May 2022 – From EuroPCR 2022
With study outcomes and clinical cases, this EuroPCR 2022 session will enable you to discuss the anatomical considerations that define suitable candidates for treatment of mitral regurgitation with the PASCAL platform and highlight key differentiators and tips and tricks for its use.
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary stenting! FANTOM II trial, five-year follow-up in the SORT OUT VIII trial, impact of side branch disease pattern on outcome following left main PCI, intravascular imaging vs. angiography-guided PCI in high bleeding risk patients, safety and...
How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast coronary interventions
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to become aware of the importance of relying on less contrast injections to guide PCI in complex patients, to learn what skills are required and tools available to perform ultra-low contrast coronary interventions, and to share and discuss such a recorded intervention from...
EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...
Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...
Double jeopardy: coronary disease in patients undergoing TAVI
17 May 2022 – From EuroPCR 2022
Through the presentation of real-life clinical cases, this session will allow you to discover the use of ALLEGRA for valve-in-valve TAVI, understand the management of coronary artery disease in TAVI patients, better detect when and how to protect coronary arteries during TAVI, or even learn how...
How to deal with calcified CTO
17 May 2022 – From EuroPCR 2022
In this dedicated session from EuroPCR 2022, listen to Gabriele Luigi Gasparini talk about procedural challenges and device selection for calcified CTO, while James Spratt looks at how to deal with long, calcified CTO, and Kambis Mashayekhi discusses problems and solutions in calcified CTO.
PCI in complex high-risk patients: acute coronary syndrome and multivessel disease PCI
19 May 2022 – From EuroPCR 2022
Consider an 86-year-old man with acute chest pain and history of HTN, HLP, DM, renal insufficiency, peripheral artery disease, PTA, urocystic cancer, and TIA, and discuss how to treat this very complex patient combining all the problems we face every day in one person.
Patient risk factors and outcome in contemporary TAVI
17 May 2022 – From EuroPCR 2022
Watch these videos to learn more about the patient's risk factors and outcome after TAVI in various situations: with atrial fibrillation and history of PCI, with Diabetes Mellitus, with aortic stenosis based on cardiac damage, and more!
Atherectomy devices: when and how to use them?
19 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to study various cases with severe calcification through which you can understand indications for rotablator or orbital atherectomy (OAS), find out more about the different device components, and learn tips and tricks.
Role of physiology during PCI
19 May 2022 – From EuroPCR 2022
Follow, LIVE from Barcelona, Spain, the case of a 61-year-old female patient, former smoker, diabetic, suffering from hypercholesterolemia, dyspnea, and chest pain on exertion for years, admitted for NYHA III heart failure, and discover the importance of physiology and intracoronary imaging in daily practice.
